(Q42449535)

31 October 2017

title

Immunotherapy for accessible tumors utilizing delayed hypersensitivity reactions and separated components of the immune system (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1271886

7 September 2022

Immunotherapy for Accessible Tumors Utilizing Delayed Hypersensitivity Reactions and Separated Components of the Immune System (English)

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31888-0

17 November 2023

1 reference

cell-mediated immunity

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1271886

7 September 2022

author name string

E. Klein

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1271886

7 September 2022

O. Holtermann

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1271886

7 September 2022

H. Milgrom

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1271886

7 September 2022

R. W. Case

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1271886

7 September 2022

D. Klein

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1271886

7 September 2022

D. Rosner

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1271886

7 September 2022

I. Djerassi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1271886

7 September 2022

language of work or name

1 reference

1 May 1976

1 reference

full work available at URL

31 October 2017

https://api.elsevier.com/content/article/PII:S0025712516318880?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31888-0

https://api.elsevier.com/content/article/PII:S0025712516318880?httpAccept=text/plain

17 November 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31888-0

Medical Clinics of North America

17 November 2023

published in

1 reference

31 October 2017

volume

60

1 reference

31 October 2017

issue

3

1 reference

31 October 2017

page(s)

389-418

1 reference

Counteractions of the blocking of cell-mediated tumor immunity by inoculation of unblocking sera and splenectomy: immunotherapeutic effects on primary polyoma tumors in rats

31 October 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31888-0

Phase I study of high doses of methotrexate with citrovorum factor in patients with lung cancer

17 November 2023

3

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31888-0

Rendering macrophages specifically cytotoxic by a factor released from immune lymphoid cells

17 November 2023

4

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31888-0

Immunologically specific activation of macrophages armed with the specific macrophage arming factor (SMAF).

17 November 2023

5

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31888-0

Serum-mediated protection of neoplastic cells from inhibition by lymphocytes immune to their tumor-specific antigens

17 November 2023

6

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31888-0

Blocking of cell‐mediated tumor immunity by sera from patients with growing neoplasms

17 November 2023

7

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31888-0

EFFECTS OF ALLERGIC CONTACT DERMATITIS ON BASAL CELL EPITHELIOMAS.

17 November 2023

8

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31888-0

Control of Carcinogenesis: A Possible Role for the Activated Macrophage

17 November 2023

9

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31888-0

In Vitro Nonimmunologic Destruction of Cells with Abnormal Growth Characteristics by Adjuvant Activated Macrophages

17 November 2023

10

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31888-0

Selective cytotoxicity of peritoneal leucocytes for neoplastic cells

17 November 2023

11

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31888-0

Local cytostatic chemotherapy and immunotherapy

17 November 2023

15

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31888-0

Hypersensitivity reactions at tumor sites

17 November 2023

17

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31888-0

Immunotherapeutic approaches to the management of neoplasms

17 November 2023

18

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31888-0

Responses of Neoplasms to Local Immunotherapy

17 November 2023

19

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31888-0

Immunologic approaches to various types of cancer with the use of BCG and purified protein derivatives

17 November 2023

20

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31888-0

Topical immunotherapy of basal cell carcinomas with dinitrochlorobenzene

17 November 2023

24

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31888-0

Inhibition of tumor growth by polyinosinic-polycytidylic acid

17 November 2023

25

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31888-0

The influence of immunologically committed lymphoid cells on macrophage activity in vivo

17 November 2023

26

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31888-0

Immunotherapy of prostatic cancer with Bacillus Calmette-Guérin and purified protein derivative. Preliminary results

17 November 2023

27

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31888-0

Regressions produced in breast cancer lesions by a lymphokine fraction from a human lymphoid cell line

17 November 2023

30

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31888-0

Delayed hypersensitivity-induced regression of human neoplasms

17 November 2023

31

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31888-0

Experiences with local chemotherapy and immunotherapy in premalignant and malignant skin lesions

17 November 2023

33

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31888-0

Inhibitory effect of injection of Corynebacterium parvum on the growth of tumour transplants in isogenic hosts

17 November 2023

34

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31888-0

17 November 2023

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1271886

7 September 2022

1 reference